- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2012
- Public Summary Document (PSD) November 2012 PBAC Meeting - PDF
Gefitinib – November 2012
Gefitinib, tablet, 250 mg, Iressa®
Last updated
8 November 2023